Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants: A Structured Review

David A Fishbain, Robert Cutler, Hubert L. Rosomoff, Renee Steele Rosomoff

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Objective. It has been hypothesized that serotonin reuptake inhibitor antidepressants (ADs) are only weakly antinociceptive but augment noradrenergic (NA) antinociception. Thus, ADs with combined serotonergic (SN) and NA activity, (i.e., the serotonergic/noradrenergic (SN/NA) ADs) should have greater antinociceptive activity versus the NA ADs, which in turn should have more antinociceptive activity than the SN ADs. The objective of this structured review was to test this hypothesis by reviewing relevant basic science literature on the treatment of experimental pain with the above different types of ADs. Design, Setting, Participants, Outcome, Measures. Animal or human experimental AD pain treatment studies were located by the usual search methods. For animal studies only placebo-controlled studies were included for review. For human studies only double blind placebo-controlled studies were selected for review. The animal and human studies were then sorted according to the pain model represented, e.g., neuropathic pain model. Studies were then characterized according to the type of AD utilized, and the antinociceptive outcome of the AD trial. Results. Twenty-two animal studies and 5 human studies fulfilled the inclusion criteria of this structured review. Within the animal nonspecific pain model there were 10 SN/NA AD trials, 9 NA AD trials and 7 SN AD trials. Of these trials 100%, 88.9%, and 14.3% respectfully demonstrated a positive AD antinociceptive effect. Overall, for all the animal models there were 25 SN/NA, 9 NA, and 8 SN trials. Of these trials 92%, 88.9%, and 25% respectfully demonstrated a positive AD antinociceptive effect. For the human pain models, only the SN/NA ADs had been utilized in 7 trials. Here in 42.8% of the trials there was a reported antinociceptive effect. Conclusions. Overall, the results of this structured review support the above hypothesis.

Original languageEnglish
Pages (from-to)310-316
Number of pages7
JournalPain Medicine
Volume1
Issue number4
StatePublished - Dec 1 2000

Fingerprint

Antidepressive Agents
Pain
Placebos
Serotonin Uptake Inhibitors
Neuralgia
Double-Blind Method
Animal Models
Outcome Assessment (Health Care)

Keywords

  • Animal Pain Models
  • Antidepressants
  • Antinociception
  • Antinociceptive Effect
  • Chronic Pain
  • Serotonergic
  • Serotonergic/Noradrenergic
  • Structured Review

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Fishbain, D. A., Cutler, R., Rosomoff, H. L., & Rosomoff, R. S. (2000). Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants: A Structured Review. Pain Medicine, 1(4), 310-316.

Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants : A Structured Review. / Fishbain, David A; Cutler, Robert; Rosomoff, Hubert L.; Rosomoff, Renee Steele.

In: Pain Medicine, Vol. 1, No. 4, 01.12.2000, p. 310-316.

Research output: Contribution to journalArticle

Fishbain, DA, Cutler, R, Rosomoff, HL & Rosomoff, RS 2000, 'Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants: A Structured Review', Pain Medicine, vol. 1, no. 4, pp. 310-316.
Fishbain, David A ; Cutler, Robert ; Rosomoff, Hubert L. ; Rosomoff, Renee Steele. / Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants : A Structured Review. In: Pain Medicine. 2000 ; Vol. 1, No. 4. pp. 310-316.
@article{5b419707deb94880bd417c6282c50dcd,
title = "Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants: A Structured Review",
abstract = "Objective. It has been hypothesized that serotonin reuptake inhibitor antidepressants (ADs) are only weakly antinociceptive but augment noradrenergic (NA) antinociception. Thus, ADs with combined serotonergic (SN) and NA activity, (i.e., the serotonergic/noradrenergic (SN/NA) ADs) should have greater antinociceptive activity versus the NA ADs, which in turn should have more antinociceptive activity than the SN ADs. The objective of this structured review was to test this hypothesis by reviewing relevant basic science literature on the treatment of experimental pain with the above different types of ADs. Design, Setting, Participants, Outcome, Measures. Animal or human experimental AD pain treatment studies were located by the usual search methods. For animal studies only placebo-controlled studies were included for review. For human studies only double blind placebo-controlled studies were selected for review. The animal and human studies were then sorted according to the pain model represented, e.g., neuropathic pain model. Studies were then characterized according to the type of AD utilized, and the antinociceptive outcome of the AD trial. Results. Twenty-two animal studies and 5 human studies fulfilled the inclusion criteria of this structured review. Within the animal nonspecific pain model there were 10 SN/NA AD trials, 9 NA AD trials and 7 SN AD trials. Of these trials 100{\%}, 88.9{\%}, and 14.3{\%} respectfully demonstrated a positive AD antinociceptive effect. Overall, for all the animal models there were 25 SN/NA, 9 NA, and 8 SN trials. Of these trials 92{\%}, 88.9{\%}, and 25{\%} respectfully demonstrated a positive AD antinociceptive effect. For the human pain models, only the SN/NA ADs had been utilized in 7 trials. Here in 42.8{\%} of the trials there was a reported antinociceptive effect. Conclusions. Overall, the results of this structured review support the above hypothesis.",
keywords = "Animal Pain Models, Antidepressants, Antinociception, Antinociceptive Effect, Chronic Pain, Serotonergic, Serotonergic/Noradrenergic, Structured Review",
author = "Fishbain, {David A} and Robert Cutler and Rosomoff, {Hubert L.} and Rosomoff, {Renee Steele}",
year = "2000",
month = "12",
day = "1",
language = "English",
volume = "1",
pages = "310--316",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants

T2 - A Structured Review

AU - Fishbain, David A

AU - Cutler, Robert

AU - Rosomoff, Hubert L.

AU - Rosomoff, Renee Steele

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Objective. It has been hypothesized that serotonin reuptake inhibitor antidepressants (ADs) are only weakly antinociceptive but augment noradrenergic (NA) antinociception. Thus, ADs with combined serotonergic (SN) and NA activity, (i.e., the serotonergic/noradrenergic (SN/NA) ADs) should have greater antinociceptive activity versus the NA ADs, which in turn should have more antinociceptive activity than the SN ADs. The objective of this structured review was to test this hypothesis by reviewing relevant basic science literature on the treatment of experimental pain with the above different types of ADs. Design, Setting, Participants, Outcome, Measures. Animal or human experimental AD pain treatment studies were located by the usual search methods. For animal studies only placebo-controlled studies were included for review. For human studies only double blind placebo-controlled studies were selected for review. The animal and human studies were then sorted according to the pain model represented, e.g., neuropathic pain model. Studies were then characterized according to the type of AD utilized, and the antinociceptive outcome of the AD trial. Results. Twenty-two animal studies and 5 human studies fulfilled the inclusion criteria of this structured review. Within the animal nonspecific pain model there were 10 SN/NA AD trials, 9 NA AD trials and 7 SN AD trials. Of these trials 100%, 88.9%, and 14.3% respectfully demonstrated a positive AD antinociceptive effect. Overall, for all the animal models there were 25 SN/NA, 9 NA, and 8 SN trials. Of these trials 92%, 88.9%, and 25% respectfully demonstrated a positive AD antinociceptive effect. For the human pain models, only the SN/NA ADs had been utilized in 7 trials. Here in 42.8% of the trials there was a reported antinociceptive effect. Conclusions. Overall, the results of this structured review support the above hypothesis.

AB - Objective. It has been hypothesized that serotonin reuptake inhibitor antidepressants (ADs) are only weakly antinociceptive but augment noradrenergic (NA) antinociception. Thus, ADs with combined serotonergic (SN) and NA activity, (i.e., the serotonergic/noradrenergic (SN/NA) ADs) should have greater antinociceptive activity versus the NA ADs, which in turn should have more antinociceptive activity than the SN ADs. The objective of this structured review was to test this hypothesis by reviewing relevant basic science literature on the treatment of experimental pain with the above different types of ADs. Design, Setting, Participants, Outcome, Measures. Animal or human experimental AD pain treatment studies were located by the usual search methods. For animal studies only placebo-controlled studies were included for review. For human studies only double blind placebo-controlled studies were selected for review. The animal and human studies were then sorted according to the pain model represented, e.g., neuropathic pain model. Studies were then characterized according to the type of AD utilized, and the antinociceptive outcome of the AD trial. Results. Twenty-two animal studies and 5 human studies fulfilled the inclusion criteria of this structured review. Within the animal nonspecific pain model there were 10 SN/NA AD trials, 9 NA AD trials and 7 SN AD trials. Of these trials 100%, 88.9%, and 14.3% respectfully demonstrated a positive AD antinociceptive effect. Overall, for all the animal models there were 25 SN/NA, 9 NA, and 8 SN trials. Of these trials 92%, 88.9%, and 25% respectfully demonstrated a positive AD antinociceptive effect. For the human pain models, only the SN/NA ADs had been utilized in 7 trials. Here in 42.8% of the trials there was a reported antinociceptive effect. Conclusions. Overall, the results of this structured review support the above hypothesis.

KW - Animal Pain Models

KW - Antidepressants

KW - Antinociception

KW - Antinociceptive Effect

KW - Chronic Pain

KW - Serotonergic

KW - Serotonergic/Noradrenergic

KW - Structured Review

UR - http://www.scopus.com/inward/record.url?scp=0013343983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013343983&partnerID=8YFLogxK

M3 - Article

C2 - 15101877

AN - SCOPUS:0013343983

VL - 1

SP - 310

EP - 316

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 4

ER -